三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
索凡替尼销售(百万美金)和增速(%)
索凡替尼销售(百万美金)和增速(%)
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:150KB
图片尺寸:1287*1208
同报告图片
/
4
5qC55o2u5Zu+54mH5Lit55qE5pWw5o2u77yM5Lul5LiL5piv6KGo5qC85bGV56S677yaCgp8IOW5tOS7vSB8IOW4guWcuumUgOWUrumine+8iOeZvuS4h+e+juWFg++8iSB8IOWinumAn++8iCXvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCAyMDIxIHwgMTEuNiAgICAgICAgICAgICAgICAgfCAgICAgICAgICB8CnwgMjAyMiB8IDMyLjMgICAgICAgICAgICAgICAgIHwgKzE3OCUgICAgfAp8IDIwMjMgfCA0My45ICAgICAgICAgICAgICAgICB8ICszNiXvvIgrNDMlIENFUu+8iSB8CgrotYTmlpnmnaXmupDvvJrlkozpu4TljLvoja/lrpjnvZHjgIHlm73kv6Hor4HliLjnu4/mtY7noJTnqbbmiYDmlbTnkIY=
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
所属报告:
和黄医药-港股公司研究报告-小分子创新药为核心商业化和出海持续兑现-240524(52页).pdf
打包全文图表
相关数据
索凡替尼全球临床研究进展
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
收藏
行业数据
2025-04-07
原图定位
查看详情
索凡替尼临床管线进展(截至2024年7月)
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
收藏
行业数据
2025-04-07
原图定位
查看详情
索凡替尼临床试验进度(截至24.7.1更新)
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
收藏
行业数据
2025-01-24
原图定位
查看详情
索凡替尼销售额(百万美元)
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
收藏
行业数据
2025-01-24
原图定位
查看详情
索凡替尼神经内分泌瘤市占率持续提升(%)
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
收藏
竞争格局
2025-01-24
原图定位
查看详情
索凡替尼:治疗NET的主要3级及以上TRAE
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
收藏
行业数据
2024-12-31
原图定位
查看详情
索凡替尼vs竞品国内NET治疗领域市场占有率
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
收藏
行业数据
2024-12-31
原图定位
查看详情
索凡替尼NET适应症销售预测(国内)
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
收藏
行业数据
2024-12-31
原图定位
查看详情
索凡替尼在所有来源的低级别神经内分泌瘤(NET)中均为I级推荐
fCDljp/lj5Hngbbpg6jkvY0gfCDliIblsYIgfCBJ57qn5o6o6I2QIHwgSUnnuqfmjqjojZAgfCBJSUnnuqfmjqjojZAgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg6IOw6IW6IHwgRzEvRzIgfCBTU0EgKElB57G7KeS+nee7tOiOq+WPuCAoSUHnsbsp57Si5Yeh5pu/5bC8IChJQeexuynoiJLlsLzmm7/lsLwgKElB57G7KUNBUFRFTSAoMkHnsbspIHwgUFJSVCAoMkHnsbsp6ZO+6ISy6ZyJ57Sg5Li65Z+656GA55qE5YyW55aX5pa55qGIICgyQeexuykgfCDovr7ljaHlt7Tll6rCseawn+Wwv+WYp+WVtiAoMkLnsbsp6KeC5a+fIHwKfCDog7DohbogfCBHMyB8IOS4tOW6iueglOeptiB8IENBUFRFTSAoMkHnsbspIHwg6IiS5bC85pu/5bC8ICgz57G7KeS+nee7tOiOq+WPuCAoM+exuylGT0xFT3ggKDJC57G7KemTvuiEsumciee0oOS4uuWfuuehgOeahOaWueahiCAoMkLnsbspUFJSVCAoM+exuylTU0EgKDPnsbspIHwKfCDog4PogqDpgZMgfCBHMS9HMiB8IFNTQSAoSUHnsbsp57Si5Yeh5pu/5bC8IChJQeexuynkvp3nu7Tojqvlj7ggKElB57G7KSB8IFBSUlQgKElB57G7KSB8IOinguWvn+WMlueWlyAoM+exuykgfAp8IOiDg+iCoOmBkyB8IEczIHwg5Li05bqK56CU56m2IHwgLSB8IOWMlueWlyAoM+exuylQUlJUICgz57G7KVNTQSAoM+exuykgfAp8IOiCuuaIluiDuOiFuiB8IOWFuOWei+exu+eZjC/pnZ7lhbjlnovnsbvnmYwgfCDntKLlh6Hmm7/lsLwgKElB57G7KeS+nee7tOiOq+WPuCAoSUHnsbspU1NBICgyQeexuykgfCDljJbnlpcgKDJC57G7KVBSUlQgKDJC57G7KSB8IOinguWvnyB8CgoK6LWE5paZ5p2l5rqQ77yaMjAyMUNTQ0/or4rnlpfmjIfljZfjgIHlvIDmupDor4HliLjnoJTnqbbmiYA=
收藏
其它
2024-06-17
原图定位
查看详情
预计索凡替尼治疗神经内分泌肿瘤患者中国销售峰值近8亿元
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
收藏
其它
2024-06-17
原图定位
查看详情
索凡替尼(苏泰坦)市占率快速提升
fCAgfCAyMDIx5bm0UTMgfCAyMDIy5bm0UTEgfCAyMDIy5bm0UTMgfCAyMDIz5bm0UTEgfCAyMDIz5bm0UTQgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg6IuP5rOw6L6+IHwgNyUgfCAxNCUgfCAxNiUgfCAxNyUgfCAyMSUgfAp8IOeUn+mVv+aKkee0oOexu+S8vOeJqSB8IDUzJSB8IDQ3JSB8IDQyJSB8IDM2JSB8IDM4JSB8Cnwg57Si5Z2mIHwgMTQlIHwgMTQlIHwgMTQlIHwgMTMlIHwgMTAlIHwKfCDpo57lsLzlpqUgfCAxMCUgfCA5JSB8IDEwJSB8IDExJSB8IDklIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOaKleWFs+adkOaWmeOAgeW8gOa6kOivgeWIuOeglOeptuaJgA==
收藏
竞争格局
2024-06-17
原图定位
查看详情
索凡替尼是中国唯一获批用于胰腺和非胰腺来源的神经内分泌瘤
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
收藏
其它
2024-06-17
原图定位
查看详情
索凡替尼发展历程
55Sx5LqO5oKo5o+Q5L6b55qE5Zu+54mH5YaF5a656L6D5Li65qih57OK77yM5peg5rOV6K+G5Yir5YW35L2T55qE5paH5a2X5YaF5a6577yM5Zug5q2k5oiR5peg5rOV5Li65oKo5o+Q5L6b5YeG56Gu55qE6KGo5qC85ZKM6LWE5paZ5p2l5rqQ44CC6K+35oKo5o+Q5L6b5pu05Yqg5riF5pmw55qE5Zu+54mH5YaF5a6577yM5Lul5L6/5oiR6IO95aSf5biu5Yqp5oKo5a6M5oiQ6L+Z5Liq5Lu75Yqh44CC
收藏
产业概述
2023-11-06
原图定位
查看详情
索凡替尼在神经内分泌瘤国内市场的占有率达到16%
5qC55o2u5Zu+54mH5Lit55qE5L+h5oGv77yM5Lul5LiL5piv5pWw5o2u55qE6KGo5qC877yaCgp8IOexu+WIqyAgIHwg5Y2g5pyJ546HIHwKfC0tLS0tLS0tfC0tLS0tLS0tfAp8IOWlpeabsuiCvSB8IDQyJSAgICB8Cnwg57Si5Yeh5pu/5bC8IHwgMTYlICAgIHwKfCDoiJLlsLzmm7/lsLwgfCAxNCUgICAgfAp8IOS+nee7tOiOq+WPuCB8IDEwJSAgICB8Cnwg5YW25LuWICAgfCAxOCUgICAgfAoK6LWE5paZ5p2l5rqQ77ya5ZKM6buE5Yy76I2vMjAyMuW5tOW5tOaKpea8lOekuuadkOaWme+8jOi0oumAmuivgeWIuOeglOeptuaJgA==
收藏
行业数据
2023-04-20
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
和黄医药在中国负责呋喹替尼和索凡替尼两款产品的商业化推广,两款产品在上市后均呈现快速增长,并且在各自适应症中占据了领先的市场占比。截至2023年底,公司共有销售人员928名(22年底为870名),其中一线销售人员778名(22年底为723名);公司共覆盖了全球332个城市、3473家医院和990家双通道药房,以及超过3.9万名肿瘤科医生。
其它
原图定位
当前图表所属:
和黄医药-港股公司研究报告-小分子创新药为核心商业化和出海持续兑现-240524(52页).pdf
赛沃替尼与奥希替尼联用的关键临床
胃癌后线治疗药物临床有效性数据
和黄医药营收测算(百万美元)
和黄医药绝对估值假设(百万美元)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》